Hairuo X. Wen
Chinese Academy Of Medical Sciences And Peking Union Medical College
Beijing, 100730, China
Beijing, 100730, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 37 publications
Allogeneic hematopoietic stem cell transplantation for 510 patients with active relapsed/refractory acute myeloid leukemia: a real-world study
Journal: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
Published: September 07, 2026
Study on In Vitro Chromosome Aberration Test for Nanomaterials and Medical Devices Containing Nanomaterials
Journal: Zhongguo yi liao qi xie za zhi = Chinese journal of medical instrumentation
Published: June 24, 2026
Determination of nitrite in rifapentine and analysis of the formation causes of nitrosamine impurity.
Journal: Frontiers in chemistry
Published: January 20, 2026
Unraveling the Obesogenic Mechanism of Bisphenol A Through Network Toxicology and Molecular Docking: Identification of Key Molecular Targets.
Journal: International journal of molecular sciences
Published: September 17, 2025
Preclinical biodistribution and safety evaluation of human iPSC-derived dopaminergic neural progenitor cells for Parkinson's disease.
Journal: Frontiers in cell and developmental biology
Published: September 09, 2025
Molecular Mechanisms of Phthalates in Depression: An Analysis Based on Network Toxicology and Molecular Docking.
Journal: International journal of molecular sciences
Published: July 22, 2025
Synthesis and mutagenic risk of avanafil's potential genotoxic impurities.
Journal: RSC advances
Published: March 27, 2024
Genotoxicity assessments of N-nitrosoethylisopropylamine (NEIPA) and N-nitrosodiisopropylamine (NDIPA) in the C57BL/6J mouse.
Journal: Mutation research. Genetic toxicology and environmental mutagenesis
Published: January 28, 2024
Safety evaluation of PEGylated MNPs and p-PEGylated MNPs in SD rats.
Journal: Scientific reports
Published: September 20, 2023
Pre-clinical efficacy of CD20-targeted chimeric antigen receptor T cells for non-Hodgkin's lymphoma.
Pre-clinical efficacy of CD20-targeted chimeric antigen receptor T cells for non-Hodgkin's lymphoma.
Journal: Discover oncology
Published: August 08, 2022
Last Updated: 09/26/2026